Contribution of the Somatosensory System to Speech Perceptual Processing

February 17, 2026 updated by: Yale University

Contribution of the Somatosensory System to Speech Perceptual Processing Aim 3

These studies test the hypothesis that the repeated pairing of somatosensory inputs with speech sounds, such as occurs during speech motor learning, results in changes to the perceptual classification of speech sounds.

Study Overview

Status

Terminated

Conditions

Detailed Description

This study will assess changes to the perceptual classification of speech sounds that are related to repeated pairing of somatosensory and auditory inputs (as would occur during speech motor learning). Before and after the training, base-line and post-training auditory perceptual performance will be examined in the absence of somatosensory stimulation, in order to evaluate the effects of the pairing on speech perception. Perceptual classification and speech motor learning will both be assessed on a 0 to 100 scale.

Study Type

Interventional

Enrollment (Actual)

160

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Quebec
      • Montreal, Quebec, Canada, H3A1G1
        • McGill University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 40 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • right handed adults
  • no known physical or neurological abnormalities

Exclusion Criteria:

  • patients with:
  • cardiac pacemaker
  • surgical clips or values on the heart
  • implants
  • metal or metallic fragments in any part of the body
  • pregnancy
  • claustrophobia
  • a personal or family history of epilepsy
  • currently taking antipsychotic drugs
  • currently taking antidepressant drugs
  • currently taking antianxiety drugs.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Adaptation to Altered Auditory Feedback
Sensorimotor adaptation in speech
Experimental: Adaptation to Altered Auditory Feedback + Forward Skin Stretch
Sensorimotor adaptation in speech
Facial skin stretch
Experimental: Adaptation to Altered Auditory Feedback + Backward Skin Stretch
Sensorimotor adaptation in speech
Facial skin stretch
Experimental: Speech Repetition Control
Sensorimotor adaptation in speech

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Speech Motor Learning
Time Frame: Performance as measured at the end of learning (30 minute session)
Learning is assessed as the change in speech sounds (speech formant frequencies) on a 0 to 100 scale.
Performance as measured at the end of learning (30 minute session)
Speech Perception
Time Frame: Perception is evaluated prior to and after perceptual training (30 minute session)
Auditory speech perception evaluates auditory classification and is assessed on a 0 to 100 scale. All conditions of skin stretch involve the same speech perception task.
Perception is evaluated prior to and after perceptual training (30 minute session)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: David Ostry, Haskins Laboratories

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2019

Primary Completion (Actual)

July 31, 2025

Study Completion (Actual)

July 31, 2025

Study Registration Dates

First Submitted

March 19, 2021

First Submitted That Met QC Criteria

March 23, 2021

First Posted (Actual)

March 26, 2021

Study Record Updates

Last Update Posted (Actual)

February 19, 2026

Last Update Submitted That Met QC Criteria

February 17, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 2000025475_b
  • R01DC017439 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe